Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

176.77B

Market cap176.77B

Price-Earnings ratio

11.28

Price-Earnings ratio11.28

Dividend yield

3.13%

Dividend yield3.13%

Average volume

15.22M

Average volume15.22M

High today

$40.10

High today$40.10

Low today

$39.64

Low today$39.64

Open price

$39.79

Open price$39.79

Volume

9.67M

Volume9.67M

52 Week high

$81.44

52 Week high$81.44

52 Week low

$35.12

52 Week low$35.12

NVO News

Investor's Business Daily 24h

Big Pharma Deepens AI Ties. What It Means For Novo, Novartis.

Technology Big Pharma Deepens AI Ties. What It Means For Novo, Novartis. Licensing Novo Nordisk (NVO) and Novartis (NVS) have forged deeper ties to AI trailblaz...

TipRanks 1d

Novo Nordisk Stock Is Cheap and Offers a 5% Dividend Yield

The stock of European pharmaceutical giant Novo Nordisk (NVO) is cheap at current levels and offers shareholders a hefty dividend yield of nearly 5%. Claim 30%...

MarketWatch 1d

Novo Nordisk’s stock rallies after drugmaker reveals deal with OpenAI

Novo Nordisk is working with OpenAI on a broad deal that will use artificial intelligence to more quickly develop new medications as well as help train its work...

Analyst ratings

63%

of 35 ratings

Buy

31.4%

Hold

62.9%

Sell

5.7%

More NVO News

Benzinga 1d

Novo Nordisk Expands AI Push With ChatGPT Parent OpenAI

AI To Accelerate Drug Discovery The collaboration will leverage advanced AI tools to analyze complex datasets, identify promising drug candidates, and streamli...

Barron's 1d

Novo Nordisk Stock Rises. An OpenAI Partnership Can Help It Find the Next Ozempic.

Biotech and Pharma Novo Nordisk Stock Rises. An OpenAI Partnership Can Help It Find the Next Ozempic. In this article NVO SPX LLY Novo Nordisk will work with Op...

TipRanks 1d

Novo Nordisk partners with OpenAI to speed drug development

Novo Nordisk (NVO) announced a strategic partnership with OpenAI that it says will place Novo Nordisk at the forefront of AI transformation in healthcare and he...

Simply Wall St 1d

Novo Nordisk’s Thalassemia Push Adds Rare Blood Upside To Valuation

Novo Nordisk (NYSE:NVO) is progressing etavopivat, a therapy candidate for thalassemia, in its rare blood disorders pipeline. The company is pairing this clini...

The Wall Street Journal 1d

Novo Nordisk and OpenAI Partner to Speed Drug Discovery

The partnership will also apply OpenAI’s capabilities to improve efficiency in manufacturing, supply chain and distribution and corporate operations. Tom Little...

TipRanks 2d

Novo Nordisk Advances DKK 15 Billion Share Buyback, Holds 0.6% in Treasury Stock as of 10 April 2026

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 5d

Novo Nordisk’s EVOKE Alzheimer’s Trial: What the Latest Update Means for NVO Investors

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decision...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.